AzTrials
AzTrials

StrokeNCT01958736

Ballistic Strength Training in Stroke: A Pilot Study

A study testing Ballistic Strength Training in people with Stroke, run by Bayside Health at 1 site in Australia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This pilot study intends to evaluate whether stroke patients can complete ballistic strength exercises for thirty minutes, three times per week over a six week training period in addition to their existing rehabilitation program. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke
What is being tested?
Ballistic Strength Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
1 siteAustralia
Study dates
Feb 2014to Sep 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Inpatient at Caulfield Hospital Neurological Rehabilitation Unit at the time of recruitment
  • Diagnosis of first stroke
  • Presence of lower limb weakness determined by >10% difference in knee extensor strength between sides
  • Functional Ambulation Category (FAC) > 3
  • Can walk a minimal distance of 14 metres (to allow measurement on a 10metre walk test (10MWT)
  • Participants who meet all the inclusion criteria except for their FAC score will have their FAC score re-measured on a weekly basis until they reach a score of greater than or equal to 3, at which point they become eligible and will be approached for recruitment.

Who cannot join

  • Unable to provide informed consent (determined by consultation with rehabilitation consultant and the team neuropsychologist)
  • Other diagnosed central nervous system disorder affecting mobility
  • Active oncological diagnosis
  • Unstable medication condition such as unstable diabetes or unstable cardiac condition that would prevent participation in cardiovascular activity
  • Recent orthopaedic trauma and/or osteoarthritis that would limit participation in physical exercise
  • Not willing to continue to attend the program if they discharge home before the end of the six week program

Trial locations and contacts

1 site in 1 country.

Australia1 site
  • Alfred Health - Caulfield Hospital

    Melbourne, Victoria, 3162

Other trials in Australia

About this study

Official title: Ballistic Strength Training in Stroke: A Phase II Randomized, Controlled, Assessor Blinded Pilot Study

This pilot study intends to evaluate whether stroke patients can complete ballistic strength exercises for thirty minutes, three times per week over a six week training period in addition to their existing rehabilitation program.

It will evaluate whether using ballistic training principles, is superior in improving mobility compared with usual care exercises to improve mobility and leg strength in stroke patients.

In this study there will be 15 participants per group, a total of 30 participants. The control group will receive usual care consistent with existing rehabilitation practice and literature. The experimental group will perform task specific strength training in a ballistic fashion.

Read the detailed description

Research Aims:

  1. To establish the feasibility of ballistic strength training in stroke and
  2. To evaluate the effects of ballistic strength training exercises on mobility outcomes, strength and quality of life when compared with usual care.

Methods:

This wil be a prospective, randomized, controlled, assessor-blinded pilot study. It will be conducted 3 x per week for 6 weeks (i.e. a total of 18 sessions lasting 30 minutes).

Primary outcome measure: Feasibility

  • Recruitment
  • Retention/Attrition
  • Clinical Feasibility
  • Safety

Secondary outcome measures - measured at baseline and completion

  • Ten metre walk test (10MWT) comfortable pace
  • 10MWT maximum safe pace
  • High level mobility assessment tool (HiMAT): Only in participants where 10MWT is <12.5s at baseline
  • Timed up and go test (TUG)
  • Functional Ambulation Category (FAC)
  • Health Related Quality of Life (HRQoL) via AQoL-4D

Description of intervention:

Control Group:

The control group will complete a suite of exercises based upon existing rehabilitation practices that aim to improve mobility after stroke. The supervising physiotherapist will select and progress the exercises, recording the performance of exercises in an exercise log and detailing incidence of adverse events. Exercise selection will include: gait retraining, cardiovascular fitness, lower limb strengthening, static and dynamic balance

Experimental group:

The experimental group will complete jump squats on the leg sled, single leg toe push offs (or bilateral where unable to complete single), alternating legs (i.e. bounding), mini tramp jumping, progressing to jogging, quick hip flexion and bounding on land.

Conditions
Stroke
Being tested
Ballistic Strength Training, Usual Care Physiotherapy
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ballistic Strength TrainingOther

    The experimental group will complete jump squats on the leg sled, single leg toe push offs (or bilateral where unable to complete single), alternating legs (i.e. bounding), mini tramp jumping, progressing to jogging, quick hip flexion and bounding on land.

  • Usual Care PhysiotherapyOther

    This group will complete a suite of exercises based upon existing rehabilitation practices that aim to improve mobility after stroke. The supervising physiotherapist will select and progress the exercises, recording the performance of exercises in an exercise log and detailing incidence of adverse events. Exercise selection will include: gait retraining, cardiovascular fitness, lower limb strengthening, static and dynamic balance.

Study groups in NCT01958736
Study groupRoleWhat they receive
ExperimentalExperimentalBallistic Strength Training
Receives: Other: Ballistic Strength Training
ControlActive comparatorUsual care Physiotherapy
Receives: Other: Usual Care Physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility

    Recruitment:

    • Number of stroke admissions to Caulfield Hospital
    • Number of stroke admissions that meet the inclusion/exclusion criteria
    • Number of those eligible who consent to participate

    Retention/Attrition:

    • Drop out rates over the six week period and reasons for drop outs
    • Number of sessions attended out of 18 over the six week period

    Clinical feasibility

    • Capacity of participants to perform the required exercises
    • Level of assistance required by therapist to perform the exercises - i.e. independent, supervision, assisted
    • Barriers to completing the required exercises during a session, i.e. incidence of delayed onset muscle soreness, fatigue
    • To be recorded for every session

    Safety

    • Incidence of adverse events
    • Types of adverse events
    • To be recorded for every session

    Measured: 6 weeks

Secondary outcomes (6)
  1. 10 metre walk test comfortable pace

    Participants will be measured at comfortable gait speed. The middle 10metres of a 14 metre track will be recorded. The participant will be asked to walk at their own comfortable speed. There will be a cone at the start and finish of the 14metre track to guide participants and the middle 10 metres will be recorded.

    Measured: Baseline and 6 weeks

  2. 10 metre walk test, maximum safe pace

    Same set-up as 10MWT comfortable pace, however the participant will be asked to walk as fast as they safely can without breaking into a run.

    Measured: Baseline and 6 weeks

  3. High level mobility assessment tool (HiMAT)

    The HiMAT is a 13 item assessment tool designed to assess high level walking tasks, the ability to negotiate stairs and the ability to run, hop, skip and jump. The HiMAT will be used to evaluate performance for higher level participants in the study where their 10MWT result may have a ceiling effect (where participants complete 10MWT in under 12.5seconds).

    Measured: Baseline and 6 weeks

  4. Timed up and go test (TUG)

    The TUG is highly reliable in stroke populations and correlates with walking performance and incidence of falls. Participants will be measured on the TUG from a 45cm chair. The will be asked to complete the test at their own comfortable speed.

    Measured: Baseline and 6 weeks

  5. Functional Ambulation Category (FAC)

    The FAC is a simple tool which uses an ordinal scale of 1 to 6 to measure the level of assistance a person requires to walk, and the different types of terrain they can manage such as indoors vs. outdoors, slopes and inclines.

    Measured: Baseline and 6 weeks

  6. Assessment of quality of life 4D

    Health related quality of Life will be measured using the Assessment of quality of life 4D. This has been shown to be a valid and sensitive measure in stroke, and has been used to determine the effects of mobility on HRQoL in neurological populations.

    Measured: Baseline and 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2013 (estimated)
  2. Study startFeb 2014
  3. Primary completionSep 2016
  4. Study completionSep 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01958736
Sponsor's protocol ID
369/13
Status last verified
Oct 2016
First submitted
7 Oct 2013
Last updated
19 Oct 2016
Results posted
No
Data monitoring committee
No

Publications

  • Hendrey G, Clark RA, Holland AE, Mentiplay BF, Davis C, Windfeld-Lund C, Raymond MJ, Williams G. Feasibility of Ballistic Strength Training in Subacute Stroke: A Randomized, Controlled, Assessor-Blinded Pilot Study. Arch Phys Med Rehabil. 2018 Dec;99(12):2430-2446. doi: 10.1016/j.apmr.2018.04.032. Epub 2018 May 30.

    PubMed 29859180

Questions about this trial

What is this clinical trial studying?

A study testing Ballistic Strength Training in people with Stroke, run by Bayside Health at 1 site in Australia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility (time frame: 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01958736, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2016; AzTrials last refreshed its copy on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in